|
Definition (NCI)
|
A synthetic 17-spironolactone corticosteroid with potassium-sparing diuretic, antihypertensive, and antiandrogen activities.Spironolactone competitively inhibits adrenocortical hormone aldosterone activity in the distal renal tubules, myocardium, and vasculature. This agent may inhibit the pathophysiologic effects of aldosterone produced in excess by various types of malignant and benign tumors.
|
|
Definition (MSH)
|
A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
|
|
Definition (CSP)
|
potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules; used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis; its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects.
|
|
Definition (PDQ)
|
A synthetic 17-spironolactone corticosteroid with potassium-sparing diuretic, antihypertensive, and antiandrogen activities. Spironolactone competitively inhibits adrenocortical hormone aldosterone activity in the distal renal tubules, myocardium, and vasculature. This agent may inhibit the pathophysiologic effects of aldosterone produced in excess by various types of malignant and benign tumors. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39444&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39444&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C840" NCI Thesaurus)
|
| Concepts |
Pharmacologic Substance
(T121)
, Steroid
(T110)
|
| MSH |
D013148
|
| SnomedCT |
13929005, 387078006 |
| LNC |
LP16280-7, MTHU003227 |
| English |
Spirolactone, Veroshpiron, Verospirone, Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, gamma-lactone, (7alpha,17alpha)-, 17-Hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic Acid, gamma Lactone, Acetate, spironolactone, Spironolactone, SPL, spironolactone (medication), SPIRONOLACTONE, Spironolactone [Chemical/Ingredient], spirolactones, spirolactone, Spironolactone (product), Spironolactone (substance) |
| Swedish |
Spironolakton
|
| Czech |
spironolakton
|
| Finnish |
Spironolaktoni
|
| Russian |
SPIROLAKTON, VEROSHPIRON, SPIRONOLAKTON, ВЕРОШПИРО�, СПИРОЛ�КТО�, СПИРО�ОЛ�КТО� |
| Japanese |
ã‚¢ãƒ�ラスノン, ダイãƒãƒ‘ール, アルパメド, アルダクトンA, ラッカルミン, メラルコン, アルダクトン, アルマトール, アレã‚サン, ホクラトン, ピãƒãƒ©ã‚¯ãƒˆãƒ³, スピãƒãƒ©ã‚¯ãƒˆãƒ³, オジãƒãƒ¼ãƒ«, スピãƒãƒŽãƒ¼ãƒ«, スピãƒãƒŽãƒ©ã‚¯ãƒˆãƒ³, ã‚¢ãƒ�タクッス |
| Italian |
Spirolattone, Spironolattone |
| Croatian |
SPIRONOLAKTON
|
| Polish |
Spironolakton, Aldakton |
| Spanish |
espironolactona (producto), espironolactona (sustancia), espironolactona, Espirolactona, Espironolactona |
| French |
Spironolactone
|
| German |
Spirolacton, Spironolacton |
| Portuguese |
Espirolactona, Espironolactona |